Long-term administration of Tolvaptan to patients with decompensated cirrhosis

Aim: Tolvaptan, an oral vasopressin-2 antagonist, sometimes improves hepatic edema including ascites in patients with decompensated cirrhosis. In this study, we examined the effectiveness and survival advantage in patients with the long-term administration of tolvaptan. Methods: A total of 115 patie...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Med Sci
Главные авторы: Kanayama, Kengo, Chiba, Tetsuhiro, Kobayashi, Kazufumi, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kusakabe, Yuko, Saito, Tomoko, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Yasui, Shin, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Kato, Naoya
Формат: Artigo
Язык:Inglês
Опубликовано: Ivyspring International Publisher 2020
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163362/
https://ncbi.nlm.nih.gov/pubmed/32308540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.41454
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы